Suscripción a Biblioteca: Guest
Journal of Environmental Pathology, Toxicology and Oncology

Publicado 4 números por año

ISSN Imprimir: 0731-8898

ISSN En Línea: 2162-6537

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.4 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.8 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.5 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00049 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.59 SJR: 0.429 SNIP: 0.507 CiteScore™:: 3.9 H-Index: 49

Indexed in

Updated Results of a Phase I Trial of Motexafin Lutetium-Mediated Interstitial Photodynamic Therapy in Patients with Locally Recurrent Prostate Cancer

Volumen 25, Edición 1-2, 2006, pp. 373-388
DOI: 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.230
Get accessGet access

SINOPSIS

Locally recurrent prostate cancer after treatment with radiation therapy is a clinical problem with few acceptable treatments. One potential treatment, photodynamic therapy (PDT), is a modality that uses laser light, drug photosensitizer, and oxygen to kill tumor cells through direct cellular cytotoxicity and/or through destruction of tumor vasculature. A Phase I trial of interstitial PDT with the photosensitizer Motexafin lutetium was initiated in men with locally recurrent prostate cancer. In this ongoing trial, the primary objective is to determine the maximally tolerated dose of Motexafin lutetium-mediated PDT. Other objectives include evaluation of Motexafin lutetium uptake from prostate tissue using a spectrofluorometric assay and evaluation of optical properties in the human prostate. Fifteen men with biopsy-proven locally recurrent prostate cancer and no evidence of distant metastatic disease have been enrolled and 14 have been treated. Treatment plans were developed using transrectal ultrasound images. The PDT dose was escalated by increasing the Motexafin lutetium dose, increasing the 732 ran light dose, and decreasing the drug-light interval. Motexafin lutetium doses ranged from 0.5 to 2 mg/kg administered IV 24, 6, or 3 hr prior to 732 ran light delivery. The light dose, measured in real time with in situ spherical detectors was 25−100 J/cm2. Light was delivered via optical fibers inserted through a transperineal brachytherapy template in the operating room. Optical property measurements were made before and after light therapy. Prostate biopsies were obtained before and after light delivery for spectrofluorometric measurements of photosensitizer uptake. Fourteen patients have completed protocol treatment on eight dose levels without dose-limiting toxicity. Grade I genitourinary symptoms that are PDT related have been observed. One patient had Grade II urinary urgency that was urinary catheter related. No rectal or other gastrointestinal PDT-related tox-icities have been observed to date. Measurements of Motexafin lutetium demonstrated the presence of photosensitizer in prostate tissue from all patients. Optical property measurements demonstrated substantial heterogeneity in the optical properties of the human prostate gland which supports the use of individualized treatment planning for prostate PDT.

CITADO POR
  1. Dimofte Andreea, Finlay Jarod C, Liang Xing, Zhu Timothy C, Determination of optical properties in heterogeneous turbid media using a cylindrical diffusing fiber, Physics in Medicine and Biology, 57, 19, 2012. Crossref

  2. Svanberg Katarina, Bendsoe Niels, Svanberg Sune, Andersson-Engels Stefan, Clinical and Technical Aspects of Photodynamic Therapy - Superficial and Interstitial Illumination in Skin and Prostate Cancer, in Handbook of Biophotonics, 2013. Crossref

  3. Xylinas E., Peyromaure M., Tratamiento del cáncer de próstata, EMC - Urología, 44, 4, 2012. Crossref

  4. Rendon Augusto, Weersink Robert, Lilge Lothar, Towards conformal light delivery using tailored cylindrical diffusers: attainable light dose distributions, Physics in Medicine and Biology, 51, 23, 2006. Crossref

  5. Svanberg K., Bendsoe N., Photodynamic therapy for human malignancies with superficial and interstitial illumination, in Lasers for Medical Applications, 2013. Crossref

  6. Svensson Tomas, Andersson-Engels Stefan, Einarsdóttír Margrét, Svanberg Katarina, In vivo optical characterization of human prostate tissue using near-infrared time-resolved spectroscopy, Journal of Biomedical Optics, 12, 1, 2007. Crossref

  7. Liang Xing, Wang Ken Kang-Hsin, Zhu Timothy C, Feasibility of interstitial diffuse optical tomography using cylindrical diffusing fibers for prostate PDT, Physics in Medicine and Biology, 58, 10, 2013. Crossref

  8. Xylinas E., Peyromaure M., Cancer de la prostate : traitements, EMC - Urologie, 5, 3, 2012. Crossref

  9. Swartling Johannes, Axelsson Johan, Ahlgren Göran, Kälkner Karl Mikael, Nilsson Sten, Svanberg Sune, Svanberg Katarina, Andersson-Engels Stefan, System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer, Journal of Biomedical Optics, 15, 5, 2010. Crossref

  10. Koreckij Theodore D., Hill Charles, Azure Larry, Nguyen Holly, Kunz Lawrence L., Azure Andrew, Corey Eva, Lange Paul, Vessella Robert L., Low dose, alternating electric current inhibits growth of prostate cancer, The Prostate, 70, 5, 2010. Crossref

  11. Svensson Tomas, Alerstam Erik, Einarsdóttír Margrét, Svanberg Katarina, Andersson-Engels Stefan, Towards accuratein vivospectroscopy of the human prostate, Journal of Biophotonics, 1, 3, 2008. Crossref

  12. Ongarora Benson G., Zhou Zehua, Okoth Elizabeth A., Kolesnichenko Igor, Smith Kevin M., Vicente M. Graça H., Synthesis, spectroscopic, and cellular properties of α-pegylated cis-A2B2- and A3B-types ZnPcs, Journal of Porphyrins and Phthalocyanines, 18, 10n11, 2014. Crossref

  13. Li Jun, Zhu Timothy C, Determination ofin vivolight fluence distribution in a heterogeneous prostate during photodynamic therapy, Physics in Medicine and Biology, 53, 8, 2008. Crossref

  14. Lindner Uri, Trachtenberg John, Lawrentschuk Nathan, Focal therapy in prostate cancer: modalities, findings and future considerations, Nature Reviews Urology, 7, 10, 2010. Crossref

  15. Balaz Milan, Collins Hazel A., Dahlstedt Emma, Anderson Harry L., Synthesis of hydrophilic conjugated porphyrin dimers for one-photon and two-photon photodynamic therapy at NIR wavelengths, Organic & Biomolecular Chemistry, 7, 5, 2009. Crossref

  16. Voon Siew Hui, Kiew Lik Voon, Lee Hong Boon, Lim Siang Hui, Noordin Mohamed Ibrahim, Kamkaew Anyanee, Burgess Kevin, Chung Lip Yong, In Vivo Studies of Nanostructure-Based Photosensitizers for Photodynamic Cancer Therapy, Small, 2014. Crossref

  17. Gómez-Veiga F., Martínez-Breijo S., Solsona-Narbón E., Hernández C., Ciudin A., Ribal M.J., Dickinson L., Moore C., Ahmed H., Rodríguez Antolín A., Breda A., Gaya J., Portela-Pereira P., Emberton M., Focal therapy for prostate cancer. Alternative treatment, Actas Urológicas Españolas (English Edition), 38, 7, 2014. Crossref

  18. Gómez-Veiga F., Martínez-Breijo S., Solsona-Narbón E., Hernández C., Ciudin A., Ribal M.J., Dickinson L., Moore C., Ahmed H., Rodríguez Antolín A., Breda A., Gaya J., Portela-Pereira P., Emberton M., Terapia focal en cáncer de próstata. Alternativas de tratamiento, Actas Urológicas Españolas, 38, 7, 2014. Crossref

  19. Moore Caroline M, Pendse Doug, Emberton Mark, Photodynamic therapy for prostate cancer—a review of current status and future promise, Nature Clinical Practice Urology, 6, 1, 2009. Crossref

  20. Ethirajan Manivannan, Chen Yihui, Joshi Penny, Pandey Ravindra K., The role of porphyrin chemistry in tumor imaging and photodynamic therapy, Chem. Soc. Rev., 40, 1, 2011. Crossref

  21. Bendsoe Niels, Photodynamic therapy: superficial and interstitial illumination, Journal of Biomedical Optics, 15, 4, 2010. Crossref

  22. Arumainayagam Nimalan, Moore C. M., Ahmed Hashim U., Emberton M., Photodynamic therapy for focal ablation of the prostate, World Journal of Urology, 28, 5, 2010. Crossref

  23. Li Hairong, Fronczek Frank R., Vicente M. Graça H., Pegylated phthalocyanines: synthesis and spectroscopic properties, Tetrahedron Letters, 52, 50, 2011. Crossref

  24. Allison Ron R., Sibata Claudio H., Oncologic photodynamic therapy photosensitizers: A clinical review, Photodiagnosis and Photodynamic Therapy, 7, 2, 2010. Crossref

  25. Li Jun, Altschuler Martin D, Hahn Stephen M, Zhu Timothy C, Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate, Physics in Medicine and Biology, 53, 15, 2008. Crossref

  26. Moore Caroline M., Emberton Mark, Bown Stephen G., Photodynamic therapy for prostate cancer-an emerging approach for organ-confined disease, Lasers in Surgery and Medicine, 43, 7, 2011. Crossref

  27. Moore Caroline M., Arumainayagam Nimalan, Emberton Mark, Energies for Focal Ablation: Photodynamic Therapy, in Focal Therapy in Prostate Cancer, 2011. Crossref

  28. Bozzini G., Colin P., Betrouni N., Nevoux P., Ouzzane A., Puech P., Villers A., Mordon S., Photodynamic therapy in urology: What can we do now and where are we heading?, Photodiagnosis and Photodynamic Therapy, 9, 3, 2012. Crossref

  29. Colin P., Estevez J.-P., Betrouni N., Ouzzane A., Puech P., Leroy X., Biserte J., Villers A., Mordon S., Thérapie photodynamique et cancer de la prostate, Progrès en Urologie, 21, 2, 2011. Crossref

  30. Mendhiratta Neil, Taneja Samir S., Focal Therapy for Prostate Cancer, in Prostate Cancer, 2016. Crossref

  31. Waidelich Raphaela, Laser-induced lithotripsy and photodynamic therapy in urology – A short introduction to current laser applications, Medical Laser Application, 25, 1, 2010. Crossref

  32. Ahmed Hashim Uddin, Moore Caroline, Emberton Mark, Minimally-invasive technologies in uro-oncology: The role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer, Surgical Oncology, 18, 3, 2009. Crossref

  33. Mroz Pawel, Bhaumik Jayeeta, Dogutan Dilek K., Aly Zarmeneh, Kamal Zahra, Khalid Laiqua, Kee Hooi Ling, Bocian David F., Holten Dewey, Lindsey Jonathan S., Hamblin Michael R., Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: Role of molecular charge, central metal and hydroxyl radical production, Cancer Letters, 282, 1, 2009. Crossref

  34. Zhu Timothy C., Finlay Jarod C., Prostate PDT dosimetry, Photodiagnosis and Photodynamic Therapy, 3, 4, 2006. Crossref

  35. Li Ziyi, Grant Kathryn B., DNA photo-cleaving agents in the far-red to near-infrared range – a review, RSC Advances, 6, 29, 2016. Crossref

  36. Dąbrowski Janusz M., Pucelik Barbara, Regiel-Futyra Anna, Brindell Małgorzata, Mazuryk Olga, Kyzioł Agnieszka, Stochel Grażyna, Macyk Wojciech, Arnaut Luis G., Engineering of relevant photodynamic processes through structural modifications of metallotetrapyrrolic photosensitizers, Coordination Chemistry Reviews, 325, 2016. Crossref

  37. Bugaj Andrzej M, Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician’s insight, World Journal of Methodology, 6, 1, 2016. Crossref

  38. Kim Michele M, Ghogare Ashwini A, Greer Alexander, Zhu Timothy C, On thein vivophotochemical rate parameters for PDT reactive oxygen species modeling, Physics in Medicine and Biology, 62, 5, 2017. Crossref

  39. Monich Victor A., Bavrina Anna P., Malinovskaya Svetlana L., Modification in oxidative processes in muscle tissues exposed to laser- and light-emitting diode radiation, Lasers in Medical Science, 33, 1, 2018. Crossref

  40. Djavan Bob, Lepor Herbert, Zare Reza, Dianat Seyed Saeid, Focal Therapy of Prostate Cancer by Radiofrequency and Photodynamic Therapy, in Image-Guided Cancer Therapy, 2013. Crossref

  41. Shafirstein Gal, Bellnier David, Oakley Emily, Hamilton Sasheen, Potasek Mary, Beeson Karl, Parilov Evgueni, Interstitial Photodynamic Therapy—A Focused Review, Cancers, 9, 12, 2017. Crossref

  42. Keca Joseph M., Zheng Gang, Texaphyrin: From molecule to nanoparticle, Coordination Chemistry Reviews, 379, 2019. Crossref

  43. Penjweini Rozhin, Wilson Brian C., Zhu Timothy C., 21 Spectroscopic imaging in prostate PDT, in Imaging in Photodynamic Therapy, 2017. Crossref

  44. Swartling Johannes, Höglund Odd V., Hansson Kerstin, Södersten Fredrik, Axelsson Johan, Lagerstedt Anne-Sofie, Online dosimetry for temoporfin-mediated interstitial photodynamic therapy using the canine prostate as model, Journal of Biomedical Optics, 21, 2, 2016. Crossref

  45. Cerruto Maria Angela, D'Elia Carolina, Artibani Walter, Focal Salvage Therapy for Locally Recurrent Prostate Cancer: A Review, Urologia Journal, 79, 4, 2012. Crossref

  46. Finlay Jarod C., Jun Li, Zhou Xiaodong, Zhu Timothy C., Patient-Specific Dosimetry for Photodynamic Therapy, in Proceedings of Light-Activated Tissue Regeneration and Therapy Conference, 12, 2008. Crossref

  47. Ridout Ashley J., Moore Caroline M., Photodynamic Therapy, in Image Guided Prostate Cancer Treatments, 2014. Crossref

  48. Yanovsky Rebecca L., Bartenstein Diana W., Rogers Gary S., Isakoff Steven J., Chen Steven T., Photodynamic therapy for solid tumors: A review of the literature, Photodermatology, Photoimmunology & Photomedicine, 35, 5, 2019. Crossref

  49. Ridout Ashley J., Emberton Mark, Moore Caroline M., Focal Photodynamic Therapy, in Technical Aspects of Focal Therapy in Localized Prostate Cancer, 2015. Crossref

  50. Wang Lang, Yang Hanfeng, Li Bing, Photodynamic therapy for prostate cancer: a systematic review and meta-analysis, Prostate International, 7, 3, 2019. Crossref

  51. Gheewala Taher, Skwor Troy, Munirathinam Gnanasekar, Photosensitizers in prostate cancer therapy, Oncotarget, 8, 18, 2017. Crossref

  52. Triesscheijn Martijn, Baas Paul, Schellens Jan H. M., Stewart Fiona A., Photodynamic Therapy in Oncology, The Oncologist, 11, 9, 2006. Crossref

  53. da Costa, Nivan B., Freire Ricardo O., Simas Alfredo M., Rocha Gerd B., Structure Modeling of Trivalent Lanthanum and Lutetium Complexes:  Sparkle/PM3, The Journal of Physical Chemistry A, 111, 23, 2007. Crossref

  54. Zuluaga Maria-Fernanda, Gabriel Doris, Lange Norbert, Enhanced Prostate Cancer Targeting by Modified Protease Sensitive Photosensitizer Prodrugs, Molecular Pharmaceutics, 9, 6, 2012. Crossref

  55. Osuchowski Michał, Bartusik-Aebisher Dorota, Osuchowski Filip, Aebisher David, Photodynamic therapy for prostate cancer – A narrative review, Photodiagnosis and Photodynamic Therapy, 33, 2021. Crossref

  56. Smith Chloe B., Days Lindsay C., Alajroush Duaa R., Faye Khadija, Khodour Yara, Beebe Stephen J., Holder Alvin A., Photodynamic Therapy of Inorganic Complexes for the Treatment of Cancer † , Photochemistry and Photobiology, 98, 1, 2022. Crossref

  57. Moore Caroline M., Bown Stephen G., Trachtenberg John, Emberton Mark, Photodynamic Therapy, in Interventional Techniques in Uro‐Oncology, 2011. Crossref

  58. Kosharskyy Boleslav, Solban Nicolas, Chang Sung K., Rizvi Imran, Chang Yuchiao, Hasan Tayyaba, A Mechanism-Based Combination Therapy Reduces Local Tumor Growth and Metastasis in an Orthotopic Model of Prostate Cancer, Cancer Research, 66, 22, 2006. Crossref

  59. Zuluaga Maria-Fernanda, Sekkat Nawal, Gabriel Doris, van den Bergh Hubert, Lange Norbert, Selective Photodetection and Photodynamic Therapy for Prostate Cancer through Targeting of Proteolytic Activity, Molecular Cancer Therapeutics, 12, 3, 2013. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain